|Articles|April 30, 2021
Analysis of Bevacizumab by SEC–MALLS
Author(s)YMC Europe GmbH
In this application note, YMC’s dedicated SEC column for antibodies, YMC-SEC MAB, has been used to develop a method for bevacizumab using MALLS detection.
Related Content
Trending on LCGC International
1
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
2
GC-MS & GC-IMS Reveal Black Tea Aroma Secrets
3
GC-MS Detection of Microbes in Spacecraft Water
4
Best of the Week: Chromatography Methods, HPLC 2026 Previews, and More
5